Nevro Receives 4 Patents for Chronic Pain Device

Nevro in Menlo Park, Calif., a medical device company, has announced the issuance of four additional key patents related to the company’s Senza(R) system and High-Frequency Spinal Cord Stimulation therapy.

Advertisement

The Senza system, which aims at providing relief from chronic pain, is available in Europe and Australia. It is presently undergoing investigation in a clinical trial in the United States.

More Articles on Pain Management:

Dr. Ritu Verma Joins American Spine
Georgia Rep. Tom Weldon to Sponsor Pain Clinic Regulation Bill
Prospira PainCare to Deploy Athenahealth’s Cloud-Based & EHR Services

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.